Biotechnology Jobs

• USA - Pennsylvania - Upper Providence
• US$188,100 – US$313,500 pa
• Director

Leads end-to-end Model-Informed Drug Development and clinical pharmacology strategy across the drug development lifecycle, from first-in-human studies through filing and lifecycle management. Designs MIDD and ClinPharm evidence strategies, drafts regulatory content for FDA, EMA, CDE, PMDA and ICH, and partners with digital medicine, translational imaging, modelling and data science teams. Sits in the newly formed Clinical Pharmacology and Quantitative Medicine organisation.

MIDD · QSP · AI/ML

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• £174,750 – £291,250 pa
• Director · manages people

Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, accountable for at least one asset or disease area and its Global Epidemiology Plan. Designs and oversees complex observational studies using claims, EHR and registry data, advises clinical, safety and regulatory matrix teams, and manages external partnerships and scientific dissemination. Also mentors junior epidemiologists and represents the company with regulators and at international conferences.

Electronic Health Records · Claims Data · Registries

• Boston, United States
• Hybrid · 2 days in office
• £174,750 – £320,375 pa
• Director · manages people

Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, designing and overseeing complex studies on disease burden, treatment patterns and safety. Partners across clinical development, safety, regulatory and health outcomes, manages external collaborations, and mentors junior scientists. Hybrid role requiring on-site presence at least two days per week.

• London
• Hybrid · 2 days in office
• £123,000 – £205,000 pa
• Director · manages people

Leads respiratory epidemiology and real-world evidence programmes that inform vaccine development, designing and overseeing complex studies on disease burden, treatment patterns and safety. Partners with clinical development, safety, regulatory and external collaborators, and mentors junior staff. Requires deep RWE and pharmaco-epidemiology expertise in a global, matrixed environment.

• Belgium-Wavre
• Hybrid · 2 days in office
• €123,000 – €205,000 pa
• Director · manages people

Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, owning the epidemiology plan for at least one asset or disease area. Designs and oversees complex observational studies using claims, EHR and registry data, advises clinical, safety and regulatory teams, and manages external partnerships while mentoring junior scientists.

Electronic Health Records · Claims Data · Registries

• Durham, United States
• US$148,500 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's global supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Establishes KPIs and reporting to track strategy impact and mitigate network risk.

• Waltham, United States
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical/QC testing network strategy across GSK's global supply chain, translating approved strategy into operational roadmaps and securing governance endorsement. Partners with Quality, MSAT, R&D and product leads on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting and risk mitigation for large molecules, ADCs and Oligos.

• London
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Benchmarks industry practice and builds KPI reporting and capability within the GSC Strategy team.

• Zebulon, United States
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical/QC testing network strategy across the global supply chain, translating approved strategy into an operational roadmap and securing endorsement from governance forums such as the Supply Chain Review Board. Partners with GSC Quality, MSAT and R&D on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting for senior leadership. Focuses on analytical testing strategy for large molecules, ADCs and Oligos.

• Upper Merion
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Collaborates with GSC Quality, MSAT and R&D, benchmarks industry best practice, and establishes KPIs and reporting for senior leadership. Focuses on analytical testing strategy for large molecules, ADCs and Oligos.

• Belgium-Wavre
• €148,500 – €247,500 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's global supply chain, defining QC testing network principles and translating them into an operational roadmap. Acts as the single point of contact in GSC Strategy, collaborating with Quality, MSAT and R&D, benchmarking industry practice and reporting KPIs to senior leadership.

• London
• Hybrid
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and interacts with regulatory authorities. Hybrid role based in the UK, Belgium, Poland or Italy.

• Poznan Grunwaldzka
• Hybrid
• £410,250 – £683,750 pa
• Director

Provides medical and scientific leadership in safety evaluation and risk management for oncology assets in clinical development, interpreting safety data, escalating signals and delivering evidence-based benefit-risk recommendations. Leads Safety Review Teams and cross-functional matrix groups, representing Safety to governance committees and regulatory authorities. Hybrid role based in the UK, Belgium, Poland or Italy.

• Belgium-Wavre
• Hybrid
• Director

Provides medical and scientific leadership in pharmacovigilance and risk management for oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and Safety Review Teams, and presents to senior governance committees and regulators. Hybrid role based in the UK, Belgium, Poland or Italy.

• Siena, Italy
• Hybrid
• £81,750 – £136,250 pa
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and may lead Safety Review Teams. The role is hybrid across the UK, Belgium, Poland or Italy, with on-site attendance for key meetings.